Trial Profile
Phase II placebo controlled study to evaluate the efficacy, safety and tolerability of RGH - 896 [radiprodil] in patients with pain due to diabetic sensor-motor peripheral neuropathy
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 25 May 2006
Price :
$35
*
At a glance
- Drugs Radiprodil (Primary)
- Indications Diabetic neuropathies; Neuropathic pain
- Focus Therapeutic Use
- 25 May 2006 New trial record.